NEW YORK, April 27, 2021 /CNW/ — MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading psychedelic medicine biotech company, is pleased to announce the start of trading on The Nasdaq Capital Market (“Nasdaq”). Trading will begin on Tuesday, April 27, 2021, under the symbol “MNMD” on the Nasdaq. As a reminder, MindMed will retain its listing on the Neo Exchange Inc. under the symbol “MMED”.


Previous articlePsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA
Next articlePT241 – Nick Meyers and Tyler Chandler of “Dosed”: Iboga and The Opioid Crisis